Simultaneously, the pro-inflammatory milieu of MASLD, characterized by elevated cytokines like IL-6 and TNF-α, further aggravates peripheral insulin resistance and pancreatic beta-cell dysfunction, directly fueling the progression of T2DM. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.